Stream Link: https://event.arraylive.com/app/login/fdee4d74-8119-4af1-a723-902054ed20dc
This activity is part 1 of a 3-part curriculum.
Program Description
Continuous glucose monitoring (CGM) technology offers unique advantages for people living with diabetes. CGM data helps identify real-time trends and patterns, allowing for more informed decisions about lifestyle and medication management. Having a foundational understanding of CGM technology, its operating principles, and available types of sensors and transmitters is imperative for pharmacists involved in diabetes care plans for patients who are considering or using CGM devices. Communication techniques to address patient concerns and optimize CGM use will also be discussed. By fostering better understanding of the benefits of CGM and facilitating CGM adoption, pharmacists can significantly contribute to optimizing blood glucose management for a wider range of patients.
Target audience: Health-system and community pharmacists
Type of activity: Application
Release date: July 16, 2024
Expiration date: September 16, 2024
Time to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Explain the burden of diabetes and the role of continuous glucose monitoring (CGM) devices in improving patient outcomes
- Compare the FDA-approved CGM devices, including enhanced features
- Identify the barriers to CGM utilization across pharmacy practice settings
- Employ strategies to improve uptake of CGM
Sara (Mandy) Reece, PharmD, CDCES, BC-ADM, BCACP
Assistant Dean for Student and Professional Affairs
Professor of Pharmacy Practice
Philadelphia College of Osteopathic Medicine School of Pharmacy
Suwanee, Georgia
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity number 0290-0000-24-152-L01-P. The activity is available for CE credit through September 16, 2024.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Faculty
Sara (Mandy) Reece, PharmD, CDCES, BC-ADM, BCACP, has the following financial relationships with commercial interests to disclose:
Consultant: Dexcom, Novo Nordisk
Speakers Bureau: Dexcom, Novo Nordisk
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Buszka, PharmD, BCPS, CHCP; Aleksandra Thomas; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms